Summary Sekisui Medical Co., Ltd. (Sekisui Medical), a subsidiary of Sekisui Diagnostics, LLC. is a medical company that develops, produces, and distributes diagnostic reagents, medical devices, pharmaceuticals, and chemicals. The company provides its services through various business divisions such as diagnostics, pharmaceuticals and fine chemicals, and ADME and Tox Research. Its pharmaceutical and chemical business manufactures and sells amino acids, pharmaceutical products in bulk, and pharmaceutical intermediates, and others. Sekisui Medical also undertakes custom synthesis of labeled compounds and evaluation tests related to pharmacokinetics through its ADME and Tox Research business. The company sells its products through in Asia, America and Europe. Sekisui Medical is headquartered in Tokyo, Japan. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Sekisui Medical Co., Ltd. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Sekisui Medical Co., Ltd. Company Snapshot 5 Sekisui Medical Co., Ltd. Company Overview 5 Sekisui Medical Co., Ltd. Pipeline Products and Clinical Trials Overview 6 Sekisui Medical Co., Ltd.- Pipeline Analysis Overview 8 Key Facts 8 Sekisui Medical Co., Ltd. - Major Products and Services 9 Sekisui Medical Co., Ltd. Pipeline Products by Development Stage 10 Sekisui Medical Co., Ltd. Pipeline Products Overview 11 CP3000 System 11 CP3000 System Product Overview 11 GL-3 - Renal 12 GL-3 - Renal Product Overview 12 KIM-1 - Renal 13 KIM-1 - Renal Product Overview 13 NADGL 14 NADGL Product Overview 14 Sekisui Medical Co., Ltd. - Key Competitors 15 Sekisui Medical Co., Ltd. - Key Employees 16 Sekisui Medical Co., Ltd. - Locations And Subsidiaries 17 Head Office 17 Other Locations & Subsidiaries 17 Recent Developments 18 Sekisui Medical Co., Ltd., Recent Developments 18 Oct 27, 2015: Sekisui Diagnostics Announces Launch of OSOM Ultra Flu A&B Test 18 Apr 22, 2015: Biomedica Launches First CE Marked FGF23 ELISA Assay In Europe and Asia 18 Apr 14, 2015: Abbott And Sekisui Collaborate To Offer Coagulation Testing For Laboratories Worldwide 18 Jun 25, 2014: Earns AAALAC Full Accreditation Japan's first AAALAC accredited pharmacokinetic CRO 19 May 10, 2011: Sekisui Medical Launches Soluble LR11 Measurement Reagents 19 Mar 30, 2011: ADME & Tox. Research Institute To Resume Operations 20 Appendix 21 Methodology 21 About GlobalData 21 Contact Us 21 Disclaimer 21
List of Tables
Sekisui Medical Co., Ltd. Pipeline Products and Clinical Trials Overview 6 Sekisui Medical Co., Ltd. Pipeline Products by Equipment Type 6 Sekisui Medical Co., Ltd. Pipeline Products by Indication 7 Sekisui Medical Co., Ltd., Key Facts 8 Sekisui Medical Co., Ltd., Major Products and Services 9 Sekisui Medical Co., Ltd. Number of Pipeline Products by Development Stage 10 Sekisui Medical Co., Ltd. Pipeline Products Summary by Development Stage 10 CP3000 System - Product Status 11 CP3000 System - Product Description 11 GL-3 - Renal - Product Status 12 GL-3 - Renal - Product Description 12 KIM-1 - Renal - Product Status 13 KIM-1 - Renal - Product Description 13 NADGL - Product Status 14 NADGL - Product Description 14 Sekisui Medical Co., Ltd., Key Employees 16 Sekisui Medical Co., Ltd., Subsidiaries 17
List of Figures
Sekisui Medical Co., Ltd. Pipeline Products by Equipment Type 7 Sekisui Medical Co., Ltd. Pipeline Products by Development Stage 10
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among otRead More...
Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in cRead More...
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliabRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.